Medication Exposure in Pregnancy Risk Evaluation Program.
To describe a program to study medication safety in pregnancy, the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP). MEPREP is a multi-site collaborative research program developed to enable the conduct of studies of medication use and outcomes in pregnancy. Collaborators include th...
| Publicado en: | Maternal & Child Health Journal Vol. 16; no. 7; pp. 1349 - 1355 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Oct2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104416426&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104416426 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10927875 N9J jtl: Maternal & Child Health Journal issn: 10927875 maglogo: N pubinfo: dt: Oct2012 vid: 16 iid: 7 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104416426 80032228 10.1007/s10995-011-0902-x NLM22002179 104416426 ppf: 1349 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Medication Exposure in Pregnancy Risk Evaluation Program. aug: au: Andrade, Susan Davis, Robert Cheetham, T. Cooper, William Li, De-Kun Amini, Thushi Beaton, Sarah Dublin, Sascha Hammad, Tarek Pawloski, Pamala Raebel, Marsha Smith, David Staffa, Judy Toh, Sengwee Dashevsky, Inna Haffenreffer, Katherine Lane, Kimberly Platt, Richard Scott, Pamela affil: Meyers Primary Care Institute, 630 Plantation St. Worcester 01605 USA sug: subj: Drug Therapy In Pregnancy Pregnancy Outcomes Drug Monitoring In Pregnancy Prenatal Exposure Delayed Effects Pregnancy Female United States United States Food and Drug Administration California Fetus Infant, Newborn Data Analysis Software Funding Source Human Fetus, conception to birth Infant, Newborn: birth-1 month Female ab: To describe a program to study medication safety in pregnancy, the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP). MEPREP is a multi-site collaborative research program developed to enable the conduct of studies of medication use and outcomes in pregnancy. Collaborators include the U.S. Food and Drug Administration and researchers at the HMO Research Network, Kaiser Permanente Northern and Southern California, and Vanderbilt University. Datasets have been created at each site linking healthcare data for women delivering an infant between January 1, 2001 and December 31, 2008 and infants born to these women. Standardized data files include maternal and infant characteristics, medication use, and medical care at 11 health plans within 9 states; birth certificate data were obtained from the state departments of public health. MEPREP currently involves more than 20 medication safety researchers and includes data for 1,221,156 children delivered to 933,917 mothers. Current studies include evaluations of the prevalence and patterns of use of specific medications and a validation study of data elements in the administrative and birth certificate data files. MEPREP can support multiple studies by providing information on a large, ethnically and geographically diverse population. This partnership combines clinical and research expertise and data resources to enable the evaluation of outcomes associated with medication use during pregnancy. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|